is chair of the FDA practice at the firm. Veleka brings more than 20 years of strategic business and legal counsel to a wide span of biopharmaceutical companies, advising on FDA regulatory and compliance matters, including 15 years of senior in-house counsel experience. Veleka’s practice provides full coverage on clinical trials and good clinical practices; current good manufacturing practices; pharmacovigilance; advertising and promotion; compounding and compliance and enforcement, including responses to warning letters and assistance with corrective and preventative actions. She also advises biopharmaceutical and private equity companies seeking to invest in or acquire compounding pharmacies, service-providers to the industry, including contract research organisations and contract manufacturing organisations, other companies or divisions of them.
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.